A team of researchers has come up with a new solution to boost the surveillance of designer drug abuse. The team has identified three new urinary biomarkers that could be used to detect consumption of ADB-BUTINACA, an emerging synthetic cannabinoid which is a type of new psychoactive substance. The innovative approach used to identify the biomarkers can be applied to other existing and new synthetic cannabinoids.
